期刊文献+

南宁市耐多药肺结核患者的发现和接受治疗情况 被引量:2

Case detection and treatment with multidrug-resistant tuberculosis in Nanning
原文传递
导出
摘要 目的分析南宁市2012—2016年耐多药肺结核患者发现和纳入治疗情况,为政府制定针对性的耐多药肺结核防治策略提供参考依据。方法收集南宁市自2012年5月—2016年12月耐多药肺结核可疑者的培养、药敏及接受治疗和转归等资料,分析不同登记分类、不同年份耐多药肺结核可疑者的涂阳培阳率、耐多药肺结核检出率以及耐多药肺结核患者的接受治疗比例。结果自2012年5月—2016年12月,南宁市共登记耐多药肺结核可疑者7987例,开展痰结核分枝杆菌培养2844例,痰培养阳性1946例,痰培养阳性率为68.42%;开展传统药敏试验1900例,经菌种鉴定结核分枝杆菌复合群1820例,检出耐多药肺结核213例,耐多药肺结核检出率为11.70%;确诊的213例耐多药肺结核患者中,纳入治疗管理106例,纳入治疗率为49.77%,接受治疗的患者中,治愈40例,完成疗程18例,治疗成功率为54.72%。结论2012—2016年南宁市耐多药肺结核防治取得一定效果,但耐多药肺结核检出率较低也可能与涂阳培阳率低导致检出例数减少有关。针对纳入治疗率和治疗成功率相对较低的问题,建议要提高耐多药肺结核患者的治疗管理水平,不断探索改进耐多药肺结核防控策略从而达到降低耐多药肺结核疫情的目的。 Objective To provide a reference for the government to develop a targeted MDR-TB prevention strategy by analyzing the findings and treatment of patients with multidrug-resistant pulmonary tuberculosis in Nanning from 2012 to 2016.Methods Data of cultivation,drug sensitivity,treatment and prognosis of suspected MDR-TB patients in our city from May 2012 to December 2016 were collected from TB management information system of CDC.The positive smear rate,detection rate and treatment rate of patients with suspected MDR-TB in different registration categories and different years were analyzed.Results From May 2012 to December 2016,7 987 suspected cases of MDR-TB were registered;2 844 cases were cultured for Mycobacterium tuberculosis in sputum,of which 1 946 cases were positive for sputum culture,and the positive rate for sputum culture was 68.42%;1 900 cases were tested for traditional drug sensitivity test,1 820 cases were identified for Mycobacterium tuberculosis complex,213 cases were detected for MDR-TB and 11.70%for MDR-TB.Of the 213 patients diagnosed as MDR-TB,106 were included in the treatment management,with a treatment rate of 49.77%.Among the patients treated,40 were cured and 18 completed the course of treatment,with a success rate of 54.72%.Conclusion The prevention and treatment of MDR-TB in Nanning City from 2012 to 2016 have achieved certain results,but the low detection rate of MDRTB may also be related to the decrease of detection cases due to the low rate of smear positive cultivation.In view of the relatively low inclusion rate and success rate of treatment,it is suggested that the treatment and management level of MDR-TB patients should be improved,and the prevention and control strategies of MDR-TB should be continuously explored so as to reduce the epidemic situation of MDR-TB.
作者 黎舒 赵亚玲 邱媛 LI Shu;ZHAO Yaling;QIU Yuan(Nanning Municipal Center for Disease Control and Prevention,Nanning,Guangxi 530012,China)
出处 《中国热带医学》 CAS 2019年第10期988-990,1008,共4页 China Tropical Medicine
关键词 耐多药肺结核 发现 治疗 转归 Multidrug-resistant tuberculosis case detection treatment outcome
  • 相关文献

参考文献13

二级参考文献91

  • 1陆普选,余卫业,朱文科,刘艳,刘锦清.艾滋病合并肺结核的影像学特征及其与CD_4^+T淋巴细胞的相关性[J].中华结核和呼吸杂志,2005,28(1):13-16. 被引量:64
  • 2中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010:25-52. 被引量:36
  • 3Zhao YL, Xu SF, Wang LX, et al. National survey of drug- resistant tuberculosis in China[ J]. The New England Journal of Medicine ,2012,366:2161 - 2170. 被引量:1
  • 4Liu Q, Zhu LM, Shao Y, et al. Rates and risk factors for drug resistance tuberculosis in northeastern China [ J] BMC Public Health ,2013,13 : 1171. 被引量:1
  • 5Alena S, Henadz H, Aksana Z, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors[ J]. Bull World Organ ,2013,91:36 - 45. 被引量:1
  • 6WHO. Guidelines for the programmatic management of drug-re- sistant tuberculosis[M] Geneva: World Health Organization, 2008. 被引量:1
  • 7WHO. Golobal Tuberculosis Report 2013 [M]. Geneva: World Health Organization, 2013. 被引量:1
  • 8WHO. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug- resistant tuberculosis (MDRTB) [M] Geneva: World Health 2000. 被引量:1
  • 9Ridderhof JC, Deun AV, Kam KM, et al. Role of laborato- ries and laboratories systems in effective tuberculosis pro- grammes [J]. Bull WHO, 2007, 85 (5) = 3S4 359. 被引量:1
  • 10Shao Y, Yang DD, Xu WG, etal. Epidemiology of anti tu- berculosis drug resistance in a chinese population: current situation and challenges ahead [J]. BMC Public Health 2011, 11= 110. 被引量:1

共引文献200

同被引文献10

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部